Infectious Diseases

Imagen equipo

Group leaders

Santiago Moreno Guillén

Sergio Serrano Villar

smguillen(ELIMINAR)@salud.madrid.org

Tlf. +34 91 336 87 10

Principal Investigator

  • Francisco Javier Cobo Reinoso
  • Jesús Fortún Abete
  • Begoña Monge Maillo
  • María Jesús Pérez Elías
  • José Antonio Pérez Molina
  • Alejandro Vallejo Tiller
  • Matilde Sánchez Conde
  • Pilar Martín Dávila
  • María Jesús Vivancos Gallego
  • Javier Martinez Sanz
  • Humberto Erick de la Torre Tarazona
  • Elena Moreno del Olmo
  • Raquel Ron González
  • Clara Crespillo Andújar
  • Maria Dolores Corbacho Loarte

Collaborating Staff

  • Santos del Campo Terrón
  • José Luis Casado Osorio
  • Fernando Dronda Núñez
  • José Manuel Hermida Donate
  • Ana María Moreno Zamora
  • Enrique Navas Elorza
  • Francesca Florence Norman
  • Vicente Pintado García
  • Carmen Quereda Rodríguez-Navarro
  • Javier Moreno García
  • Rosa Escudero Sánchez
  • Sandra Chamorro Tojeiro
  • Daniel de Las Heras Gomez
  • Laura Martín Pedraza
  • Claudio Diaz Garcia
  • Jorge Diaz Alvarez
  • Alejandro Garcia Garcia
  • Rogelio López-Vélez Pérez
  • Miguel Suárez Robles
  • Ana del Amo de Palacios
  • Sara Saiz Baggetto
  • Diego Gayoso Cantero
  • Sergio Calderón Vicente
  • Valentina Leguizamón
  • Samuel García Huete
  • Roser Navarro Soler
  • Marta Gonzalez Sanz
  • Alvaro Gonzalez Camuesco
  • Ignacio Peña Ruiz
  • Cristina Arcas Noguera
  • Martina Corral Aller
  • Marta Rosas Cancio-Suarez
  • Laura Luna García
Imagen equipo

Group leaders

Santiago Moreno Guillén

Sergio Serrano Villar

smguillen(ELIMINAR)@salud.madrid.org

Tlf. +34 91 336 87 10

Principal Investigator

  • Francisco Javier Cobo Reinoso
  • Jesús Fortún Abete
  • Begoña Monge Maillo
  • María Jesús Pérez Elías
  • José Antonio Pérez Molina
  • Alejandro Vallejo Tiller
  • Matilde Sánchez Conde
  • Pilar Martín Dávila
  • María Jesús Vivancos Gallego
  • Javier Martinez Sanz
  • Humberto Erick de la Torre Tarazona
  • Elena Moreno del Olmo
  • Raquel Ron González
  • Clara Crespillo Andújar
  • Maria Dolores Corbacho Loarte

Collaborating Staff

  • Santos del Campo Terrón
  • José Luis Casado Osorio
  • Fernando Dronda Núñez
  • José Manuel Hermida Donate
  • Ana María Moreno Zamora
  • Enrique Navas Elorza
  • Francesca Florence Norman
  • Vicente Pintado García
  • Carmen Quereda Rodríguez-Navarro
  • Javier Moreno García
  • Rosa Escudero Sánchez
  • Sandra Chamorro Tojeiro
  • Daniel de Las Heras Gomez
  • Laura Martín Pedraza
  • Claudio Diaz Garcia
  • Jorge Diaz Alvarez
  • Alejandro Garcia Garcia
  • Rogelio López-Vélez Pérez
  • Miguel Suárez Robles
  • Ana del Amo de Palacios
  • Sara Saiz Baggetto
  • Diego Gayoso Cantero
  • Sergio Calderón Vicente
  • Valentina Leguizamón
  • Samuel García Huete
  • Roser Navarro Soler
  • Marta Gonzalez Sanz
  • Alvaro Gonzalez Camuesco
  • Ignacio Peña Ruiz
  • Cristina Arcas Noguera
  • Martina Corral Aller
  • Marta Rosas Cancio-Suarez
  • Laura Luna García

Strategic objectives

  • To delve into the determinants and pathogenic mechanisms of infectious diseases that cause health problems in our environment, with special emphasis on environmental, host, and microorganism-related factors.
  • To determine the best diagnostic, therapeutic, and preventive approaches for diseases caused by bacteria, viruses, fungi, or parasites prevalent in our environment.
  • To explore, in collaboration with national and international groups, the mechanisms of HIV persistence and the pharmacological interventions that can contribute to its eradication.
  • To understand the characteristics of infectious diseases affecting immigrants in Spain and travelers to tropical and subtropical areas, focusing on diagnostic and therapeutic procedures.
  • To define strategies for optimizing the use of antimicrobials in the treatment of community-acquired and hospital-acquired infections, achieving maximum efficacy with minimal toxicity for patients, minimal impact on the ecosystem, and minimal pharmaceutical expenditure. To define the mechanisms by which the microbiome contributes to the pathogenesis of infectious and non-infectious diseases and to harness its potential to identify biomarkers and therapeutic targets.

Research lines

  • HIV infection.
  • Imported infectious diseases (Tropical Medicine)
  • Infectious diseases in healthy and immunocompromised individuals.
  • Clinical applications of the microbiome.

Location

Ramón y Cajal University Hospital

Immunovirology Laboratory and Clinical Trials Unit for General Infectious Diseases. 4th Floor, Central Building

Control A Clinical Trials Unit for HIV Infection and Tropical Medicine. Outpatient Clinic Building, Ground Floor

Keywords

Infection, HIV, immunocompromised, antibiotic, antiviral, antiparasitic, antifungal, hepatitis, human papillomavirus, sexually transmitted infection